WHO ICTRP trial
GENPAD
CTIS2024-518122-33-00 · EU Clinical Trials Information System · Not Recruiting
Key facts
| Trial ID | CTIS2024-518122-33-00 |
|---|---|
| Public title | GENPAD |
| Scientific title | Genotype-guided strategy for antithrombotic treatment versus conventional clopidogrel therapy in peripheral arterial disease (GENPAD) |
| Primary sponsor | Radboud universitair medisch centrum Stichting |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): No Therapeutic exploratory (Phase II): No Therapeutic confirmatory - (Phase III): No Therapeutic use - (Phase IV): Yes |
| Countries | Netherlands |
| Conditions | Peripheral Arterial Disease;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14] |
| Interventions | Product Name: , Product Code:SCP131039, Pharmaceutical Form: , Other descriptive name: , Strength: , Product Name: , Product Code:SCP1108233, Pharmaceutical Form: , Other descriptive name: , Strength: , Product Name: , Product… |
| Registration date | Oct 14, 2024 |
| Target size | 2276 |
| Secondary IDs | NCT04619927;2020-004913-11 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: